DE68910713T2 - Isolierung, Reinigung, Charakterisierung, Klonierung und Sequenzierung von N-alpha-Acetyltransferase. - Google Patents

Isolierung, Reinigung, Charakterisierung, Klonierung und Sequenzierung von N-alpha-Acetyltransferase.

Info

Publication number
DE68910713T2
DE68910713T2 DE89102006T DE68910713T DE68910713T2 DE 68910713 T2 DE68910713 T2 DE 68910713T2 DE 89102006 T DE89102006 T DE 89102006T DE 68910713 T DE68910713 T DE 68910713T DE 68910713 T2 DE68910713 T2 DE 68910713T2
Authority
DE
Germany
Prior art keywords
acetyltransferase
cloning
sequencing
characterization
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE89102006T
Other languages
English (en)
Other versions
DE68910713D1 (de
Inventor
John A Smith
Fang-Jen S Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of DE68910713D1 publication Critical patent/DE68910713D1/de
Application granted granted Critical
Publication of DE68910713T2 publication Critical patent/DE68910713T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/94—Saccharomyces
    • Y10S435/942—Saccharomyces cerevisiae
DE89102006T 1988-02-08 1989-02-06 Isolierung, Reinigung, Charakterisierung, Klonierung und Sequenzierung von N-alpha-Acetyltransferase. Expired - Fee Related DE68910713T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15336188A 1988-02-08 1988-02-08
US07/284,344 US4966848A (en) 1988-02-08 1988-12-14 Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase

Publications (2)

Publication Number Publication Date
DE68910713D1 DE68910713D1 (de) 1993-12-23
DE68910713T2 true DE68910713T2 (de) 1994-04-07

Family

ID=26850470

Family Applications (1)

Application Number Title Priority Date Filing Date
DE89102006T Expired - Fee Related DE68910713T2 (de) 1988-02-08 1989-02-06 Isolierung, Reinigung, Charakterisierung, Klonierung und Sequenzierung von N-alpha-Acetyltransferase.

Country Status (9)

Country Link
US (1) US4966848A (de)
EP (1) EP0334004B1 (de)
JP (1) JPH03502403A (de)
DE (1) DE68910713T2 (de)
DK (1) DK186390A (de)
ES (1) ES2061745T3 (de)
IE (1) IE890386L (de)
PT (1) PT89611B (de)
WO (1) WO1989007138A1 (de)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128459A (en) * 1988-02-08 1992-07-07 The General Hospital Corporation Isolation, purification, characterization, cloning and sequencing of N alpha-acetyltransferase
US5656458A (en) * 1988-11-04 1997-08-12 Chiron Corporation Expression and processing of amino terminus acetylated FGF's in yeast
US5223421A (en) * 1989-10-25 1993-06-29 The General Hospital Corporation Identification of methionine Nα-acetyltransferase
CA2071486A1 (en) * 1989-10-25 1991-04-26 John A. Smith Isolating of strains of saccharomyces cerevisiae having altered n.alpha.-acetyltransferase activity
US8680059B2 (en) * 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
NO986133D0 (no) 1998-12-23 1998-12-23 Preben Lexow FremgangsmÕte for DNA-sekvensering
EP1300418A1 (de) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Genregulation durch Oligopeptide
FR2807523B1 (fr) * 2000-04-07 2002-08-30 Inst Nat Sante Rech Med UTILISATION D'UN RESTE PyA-(Z)x-pNF A DES FINS DE DETECTION, IDENTIFICATION ET/OU DOSAGE PAR FLUORESCENCE
US20030109457A1 (en) * 2001-10-25 2003-06-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
GB2368339B (en) 2000-10-26 2002-09-18 Yissum Res Dev Co Complex incorporating a plurality of antioxidants
DE10106852A1 (de) 2001-02-14 2002-09-05 T Luger Entzündungshemmende Verbindungen
US7528227B2 (en) * 2004-03-23 2009-05-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Histone H2A peptide derivatives and uses thereof
EP1432728A4 (de) * 2001-08-30 2007-10-24 Praecis Pharm Inc Verfahren und zusammensetzungen zur behandlung entzündlicher erkrankungen
US7238671B2 (en) * 2001-10-18 2007-07-03 Bristol-Myers Squibb Company Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
US7786084B2 (en) * 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US20080318871A1 (en) * 2001-12-21 2008-12-25 Khan Nisar A Treatment of neurological disorders
US20080242837A1 (en) * 2001-12-21 2008-10-02 Khan Nisar A Peptide compositions
EP1601961A1 (de) * 2003-03-07 2005-12-07 University College Cork-National University of Ireland, Cork Prozess zur synthese einer chromatographischen phase
US20080023859A1 (en) * 2003-11-28 2008-01-31 Toagosei Co., Ltd. Glycopeptides and Temperature-Responsive Micelles
US20090227505A1 (en) * 2004-01-07 2009-09-10 Biotempt B.V. Methods and uses for protein breakdown products
EP1785431B1 (de) * 2004-08-30 2016-01-20 Toray Industries, Inc. Fraktionierungsvorrichtung
EP1802655B1 (de) * 2004-10-18 2013-07-24 BASF Beauty Care Solutions S.A.S. Oligopeptide und deren verwendung in kosmetika
US7563764B2 (en) * 2004-12-30 2009-07-21 E. I. Du Pont De Nemours And Company Antimicrobial peptides based on tripeptide repeats
MX2007008744A (es) 2005-01-20 2008-03-10 Biomarck Pharmaceuticals Ltd Inhibidores de hipersecrecion de mucina con base en la estructura de mans ymetodos de uso.
JP4846799B2 (ja) * 2005-07-05 2011-12-28 バイオテンプト ベー．フェー． 腫瘍の治療
EP1782819A1 (de) 2005-11-03 2007-05-09 Cognis IP Management GmbH Oligopeptide und deren Verwendung
TWI303567B (en) * 2005-12-20 2008-12-01 Ind Tech Res Inst Oligopeptide, derivative thereof, and pharmaceutical composition comprising the same
US20100160207A1 (en) * 2006-02-16 2010-06-24 University Of Georgia Research Foundation, Inc. Feedback Prodrug
ZA200807028B (en) * 2006-02-23 2009-11-25 Fibrex Medical Res & Dev Gmbh Peptides and peptide derivatives as well as pharmaceutical compositions containing the same
EP1864692A1 (de) * 2006-06-07 2007-12-12 Biotempt B.V. Verwendung von peptiden zum Schutz von Strahlenschäden
FR2900826B1 (fr) * 2006-05-12 2008-08-15 Soc Extraction Principes Actif Utilisation de peptides en tant que principes actifs amincissants.
CA2658949C (en) * 2006-07-26 2014-04-22 Biomarck Phamaceuticals, Ltd. Inhibition of marcks-mediated degranulation by marcks n-terminal pepetides in treating inflammation
US8507434B2 (en) * 2007-01-03 2013-08-13 The Johns Hopkins University Peptide modulators of angiogenesis and use thereof
SG178780A1 (en) * 2007-02-12 2012-03-29 Biotempt Bv Treatment of trauma-hemorrhage with short oligopeptides
AU2009275135A1 (en) * 2008-07-21 2010-01-28 Compugen Ltd. Angiopoietin derived peptides
FR2940969B1 (fr) * 2009-01-09 2012-05-04 Isp Investments Inc Nouveaux peptides anti-age et composition cosmetique et/ou pharmaceutique les contenant
WO2011068978A1 (en) * 2009-12-02 2011-06-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methanocarba adenosine derivatives and dendrimer conjugates thereof
EP2382963A1 (de) * 2010-04-29 2011-11-02 Cognis IP Management GmbH Kosmetische Zusammensetzung mit Oligopeptiden
JP5943433B2 (ja) * 2011-01-20 2016-07-05 ワンデイ − バイオテク アンド ファーマ リミテッド 抗酸化、抗炎症、抗放射線、金属キレート化合物およびその使用
WO2012123018A1 (en) * 2011-03-15 2012-09-20 Nanomed3D S.R.L. Functionalized biomaterials for tissue regeneration
KR101285259B1 (ko) * 2011-08-04 2013-07-11 (주)케어젠 Ｗｎｔ 계열 유래 펩타이드 및 이의 용도
US9452225B2 (en) * 2012-03-01 2016-09-27 Novo Nordisk A/S GLP-1 prodrugs
WO2014016831A1 (en) 2012-07-23 2014-01-30 Oneday - Biotech And Pharma Ltd. Glutathione-elevating compositions and uses thereof
WO2014016837A1 (en) 2012-07-25 2014-01-30 Oneday - Biotech And Pharma Ltd. Compositions and methods for increasing carnitine level in muscle tissues
EP2891663B8 (de) * 2012-08-31 2018-04-04 Vasculead Inc. Psf1-abgeleitete peptide
US20150265710A1 (en) * 2012-10-17 2015-09-24 Novo Nordisk A/S Fatty Acid Acylated D-Amino Acids for Oral Peptide Delivery
ES2952367T3 (es) * 2014-05-11 2023-10-31 Tel Hashomer Medical Res Infrastructure & Services Ltd Conjugados terapéuticos basados en PAR-1 y usos de los mismos
KR101470793B1 (ko) * 2014-06-30 2014-12-08 순천향대학교 산학협력단 흡수촉진제로서의 펩타이드와 이를 포함하는 조성물
JPWO2016129174A1 (ja) * 2015-02-09 2017-11-16 株式会社ファーマフーズ ヒアルロン酸産生促進剤
US9856302B2 (en) * 2015-07-23 2018-01-02 General Biologicals Corporation Anti-microbial peptide and method for treating microbial infection
WO2017049140A2 (en) * 2015-09-18 2017-03-23 Wake Forest University Health Sciences Angiotensin (1-7) analogs and methods relating thereto
CN108290056B (zh) * 2015-12-14 2021-09-14 曹友平 短合成肽及其用途
US10286038B2 (en) * 2016-03-11 2019-05-14 Northwestern University Lysosome membrane protein 2 (LIMP-2) based peptides and related uses
US11759496B2 (en) * 2016-05-10 2023-09-19 Philippe Karoyan Compounds and pharmaceutical use thereof in the treatment of cancer
US10981980B2 (en) * 2016-06-15 2021-04-20 Counterpoint Biomedica Llc Polypeptide targeting aptamers for characterization, capture, and clinical management of circulating tumor cells
SG11201901393VA (en) * 2016-09-02 2019-03-28 Univ Illinois Kif13b-derived peptide and method of inhibiting angiogenesis
JP2020513418A (ja) * 2016-12-13 2020-05-14 エモリー ユニバーシティ ウイルス感染を管理するためのポリペプチド
US11116817B2 (en) * 2017-02-17 2021-09-14 The Curators Of The University Of Missouri Antimicrobial agents and compositions comprising the same
US10570177B2 (en) * 2017-03-01 2020-02-25 The Chinese University Of Hong Kong P3 peptidylic inhibitors for treating CAG-repeat RNA toxicity in polyglutamine diseases
RU2678987C2 (ru) * 2017-04-28 2019-02-05 Общество с ограниченной ответственностью "Научно-производственная фирма ВЕРТА" Пептид для лечения болезни альцгеймера
IL278311B2 (en) 2018-05-02 2024-02-01 Tel Hashomer Medical Res Infrastructure & Services Ltd Preparations and methods for the treatment of glioblastoma
KR102234027B1 (ko) * 2018-05-09 2021-03-31 서울대학교산학협력단 B형 간염 바이러스 유래 폴리펩티드 및 이의 항바이러스 용도
CN113853382A (zh) * 2019-01-07 2021-12-28 森纳生物科学公司 新型肽及其用途
US11685766B2 (en) 2019-05-08 2023-06-27 Creighton University 14-3-3 targeting peptides for cancer treatment
WO2020227625A1 (en) * 2019-05-08 2020-11-12 Laura Hansen 14-3-3 targeting peptides for cancer treatment
US20210009639A1 (en) 2019-07-12 2021-01-14 Northwestern University Insulin like growth factor binding protein bioactive peptide fragments

Also Published As

Publication number Publication date
DE68910713D1 (de) 1993-12-23
WO1989007138A1 (en) 1989-08-10
ES2061745T3 (es) 1994-12-16
AU616492B2 (en) 1991-10-31
DK186390D0 (da) 1990-08-03
JPH03502403A (ja) 1991-06-06
EP0334004B1 (de) 1993-11-18
DK186390A (da) 1990-08-03
EP0334004A1 (de) 1989-09-27
IE890386L (en) 1989-08-08
PT89611B (pt) 1994-05-31
PT89611A (pt) 1989-10-04
AU3196989A (en) 1989-08-25
US4966848A (en) 1990-10-30

Similar Documents

Publication Publication Date Title
DE68910713D1 (de) Isolierung, Reinigung, Charakterisierung, Klonierung und Sequenzierung von N-alpha-Acetyltransferase.
DE68917729D1 (de) Reinigung und verabreichung von dns-reparatur-enzymen.
DE3689427D1 (de) Klonierung von Restriktions- und Modifikationsgenen.
NO874357D0 (no) Rensing av pichia-produserte lipofile proteiner.
DE69206580D1 (de) Silikontetrahydrazide und Reinigung von DNS.
DE3789880D1 (de) Isolierung und Expression von bei der Biosynthese von Beta-Laktamen beteiligten Genen.
DE68912685D1 (de) Reinigung von Glucosaminoglucan abbauenden Enzymen.
DE3770184D1 (de) Behandlung von gasstroemen.
DE3777861D1 (de) Behandlung von gasen.
DE3481307D1 (de) Aglykone und pseudo-aglykone von aad-216-antibiotika.
NO873325L (no) Sekresjon av heterologe proteiner av gjaer.
DE3789530D1 (de) Klonierung und Expression des sauren Fibroblastenwachstumsfaktors.
DE3751576D1 (de) Virale Inaktivierung und Reinigung von aktiven Proteinen.
DE3650319T2 (de) Klonierung und expression von wirtsschützenden immunogenen des infektioesen bursavirus (ibdv).
DE3684650D1 (de) Klonierung und charakterisierung des rinder-interleukin-2-gens.
DE3780506D1 (de) Reinigung des einkettigen und zweikettigen gewebeplasminogenaktivators.
DE3885913D1 (de) Aufbereitung von Alkoxysilanen.
DK93886D0 (da) Molekylaer kloning af delta-endotoksingenet af bacillus thuringiensisvar. isroelensis
NO874490D0 (no) Kloning og anvendelse av transaminasegenet ilv-e.
ATE97442T1 (de) Isolierung, reinigung, charakterisierung, klonierung und sequenzierung von n-alphaacetyltransferase.
DE3675063D1 (de) Mischungen von polycaprolactonpolyolen und polyepoxyden.
DE3769332D1 (de) Derivate von pyrido-menadion-additionsprodukten und verwendungen davon.
FI871616A (fi) Foerfarande foer framstaellning av n-(sulfonylmetyl)formamider.
DE3672892D1 (de) Herstellung von s-aryl-s-alkyl-dithiocarbonaten, arylthiolen und arylthioethern.
ATE74378T1 (de) Klonierung und charakterisierung des rinderinterleukin-2-gens.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee